News - Aeterna Zentaris announces that final data for the Phase 1 portion of the ongoing Phase 1/2 trial with its lead oncology compound, zoptarelin doxorubicin (AEZS-108), demonstrated the compound's promising anti-tumor activity in heavily pre treated men with castration- and taxane-resistant prostate cancer. Results were presented earlier today by lead investigator, Jacek Pinski, MD, PhD, of the USC Norris Comprehensive Cancer Center, during a poster session at the American Society of Clinical Oncology's ("ASCO") Annual Meeting in San Francisco.
News - Provincial Airlines is a major provider of scheduled flight services, air charters, air cargo services and air ambulance. They serve 18 destinations throughout Newfoundland and Labrador, Nova Scotia, New Brunswick and Québec.
News - On June 8th, Delta Air Lines will begin a daily service to New York’s JFK airport. Travellers will now have access to two flights a day to the airport with the most international passengers in the United States. “The addition of JFK to our flight offering is excellent news. Not only will there be more ways to get directly to New York, but our passengers will also benefit from another major hub for world travel. This new flight will also open our region to international tourists and business people
News - Nyx Hemera Technologies, the designer and developer of the TLACS (Tunnel Lighting Addressable Control System), today announced the launch of the TLACS for LED lighting systems in road tunnels.
News - LeddarTech today announced the closing of its latest round of venture capital financing for $2.5 million. LeddarTech is the owner of the patented LeddarTM LED-based detection technology, a 3D detection solution that combines LED lighting and innovative signal processing into an accurate and robust detection solution. iSource, Accès Capital and Desjardins-Innovatech also participated in the financing led by GO Capital LP and BDC Venture Capital.
News - Frank T. Piller holds the Chair of Managementat RWTH Aachen University (RWTH), where he directs the Technology & Innovation Management Group. In addition to being one of Europe’s most prestigious institutions, RWTH is regarded as the top German university for the quality of the engineers and managers it graduates (WirtschaftsWoche, April 2013).
News - Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced that the company will present four posters at the 2013 American Thoracic Society (ATS) International Conference, taking place May 17-22 in Philadelphia. All four will describe data around ASM-024, Asmacure's lead development compound, currently in development for asthma and chronic obstructive pulmonary disease.
News - Atrium Innovations Inc., an international manufacturer and distributor of science-based dietary supplements, is planning an acquisition in the $100-million range after completing its current vertical integration program, CEO Pierre Fitzgibbon said Tuesday.
News - Desjardins Group has been recognized for its manufacturing capabilities once again, receiving the esteemed Structured Products House of the Year Canada Award during a ceremony in Coral Gables, Florida on May 2. The prize was awarded by the internationally renowned London-based magazine Structured Products and recognized Desjardins’ innovation in the manufacturing of structured products in 2012.
News - Atrium Innovations announces that it has extended its research partnership with the Institute of Nutrition and Functional Foods ("INAF"). In June 2011, Atrium launched a comprehensive applied clinical research program in collaboration with INAF at Université Laval in Quebec City. The original program was funded through the end of 2013.